Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, Sara Labiano, Maria A. Aznar, Iñaki Etxeberria, Alvaro Teijeira, Maria E. Rodriguez-Ruiz, Jose L. Perez-Gracia, Maria Jure-Kunkel, Juan M. Zapata, Manuel S. Rodriguez, Ignacio Melero

Open source

DOI
10.1080/2162402x.2017.1368605
Published
2017-09-21
Container
OncoImmunology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/2162402x.2017.1368605,
  title = {Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)},
  author = {Arantza Azpilikueta and Elixabet Bolaños and Valerie Lang and Sara Labiano and Maria A. Aznar and Iñaki Etxeberria and Alvaro Teijeira and Maria E. Rodriguez-Ruiz and Jose L. Perez-Gracia and Maria Jure-Kunkel and Juan M. Zapata and Manuel S. Rodriguez and Ignacio Melero},
  year = {2017},
  journal = {OncoImmunology},
  doi = {10.1080/2162402x.2017.1368605},
  url = {https://doi.org/10.1080/2162402x.2017.1368605}
}

RIS

TY  - JOUR
TI  - Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)
AU  - Arantza Azpilikueta
AU  - Elixabet Bolaños
AU  - Valerie Lang
AU  - Sara Labiano
AU  - Maria A. Aznar
AU  - Iñaki Etxeberria
AU  - Alvaro Teijeira
AU  - Maria E. Rodriguez-Ruiz
AU  - Jose L. Perez-Gracia
AU  - Maria Jure-Kunkel
AU  - Juan M. Zapata
AU  - Manuel S. Rodriguez
AU  - Ignacio Melero
PY  - 2017
JO  - OncoImmunology
DO  - 10.1080/2162402x.2017.1368605
UR  - https://doi.org/10.1080/2162402x.2017.1368605
ER  - 

APA

Azpilikueta, A., Bolaños, E., Lang, V., Labiano, S., Aznar, M. A., Etxeberria, I., Teijeira, A., Rodriguez-Ruiz, M. E., Perez-Gracia, J. L., Jure-Kunkel, M., Zapata, J. M., Rodriguez, M. S., & Melero, I. (2017). Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB). OncoImmunology. https://doi.org/10.1080/2162402x.2017.1368605

Source records